Surgical solutions
Enhance surgical outcomes with evidence-based solutions
When it comes to protecting patients, we’re on the same team. You’re at the forefront of care, and we’re here to help you reduce the risk of preventable complications like surgical site infections (SSIs). Why? Because SSIs take a tremendous toll on patients, healthcare professionals and facilities. Therefore, it’s important to take steps to help reduce your patient’s infection risk factors.
Choose from a variety of evidence-based surgical solutions to help you mitigate the risk of SSIs, protect patients and staff and improve outcomes — for every patient, every time.
Help lower the risk of infection
Antimicrobial Incise Drapes
The risk of a patient contracting an SSI during surgery can be emotionally devastating and harmful to their well-being and recovery. Additionally, SSIs can place a huge operational and financial burden on healthcare systems and professionals.
For more than 40 years, you've trusted our 3M™ Ioban™ 2 Antimicrobial Incise Drape to:
Provide continuous antimicrobial activity
Contains an antimicrobial agent and provides continuous broad-spectrum antimicrobial activity to help reduce the risk of surgical site contamination that may be associated with SSI.
Immobilise bacteria
Immobilises bacteria on the skin, helping to prevent migration into the surgical incision area.
Create a sterile surface
Creates a sterile, physical barrier which reduces the risk of contamination that can lead to a costly and potentially devastating SSI. The skin is never sterile. However, using an Ioban 2 Antimicrobial Incise Drape allows you to create a sterile surface all the way up to the wound edge and provides continuous broad-spectrum antimicrobial activity during surgical procedures.
Offer quick, easy drape placement
Adheres securely to the skin, ensuring stability during surgery.
References:
- Smyth ET et al. (2008) Four Country Healthcare Associated Infection Prevalence Survey 2006: Overview of the results. Journal of Hospital Infection; 69:230–48.
- Canadian Surgical Site Infection Prevention Audit Month Report. Retrieved from http://www.patientsafetyinstitute.ca/en/toolsResources/Pages/SSI-Audit-Recap-Report-2016-12.aspx
- Anderson DJ, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009;4(12):e8305. doi: 10.1371/journal.pone.0008305.
- 3M Data on File. EM-05-014815.
- Global healthcare Exchange (Q32013). i. video.
- Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. May 2017;96(1):1-15. doi:10.1016/j.jhin.2017.03.004